BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $289,264 | -17.1% | 7,612 | 0.0% | 0.01% | -15.4% |
| Q2 2023 | $348,790 | +12.2% | 7,612 | 0.0% | 0.01% | +8.3% |
| Q1 2023 | $310,730 | -15.6% | 7,612 | +5.9% | 0.01% | -25.0% |
| Q4 2022 | $368,083 | -5.4% | 7,185 | 0.0% | 0.02% | -11.1% |
| Q3 2022 | $389,000 | +8.1% | 7,185 | +28.6% | 0.02% | +12.5% |
| Q2 2022 | $360,000 | -7.7% | 5,585 | +10.9% | 0.02% | +6.7% |
| Q1 2022 | $390,000 | -6.0% | 5,035 | +4.1% | 0.02% | +7.1% |
| Q4 2021 | $415,000 | +6.7% | 4,835 | 0.0% | 0.01% | -33.3% |
| Q3 2021 | $389,000 | 0.0% | 4,835 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $389,000 | -4.7% | 4,835 | 0.0% | 0.02% | -16.0% |
| Q1 2021 | $408,000 | +5.2% | 4,835 | 0.0% | 0.02% | -3.8% |
| Q4 2020 | $388,000 | -0.3% | 4,835 | 0.0% | 0.03% | -13.3% |
| Q3 2020 | $389,000 | -6.5% | 4,835 | 0.0% | 0.03% | -14.3% |
| Q2 2020 | $416,000 | +5.9% | 4,835 | 0.0% | 0.04% | -14.6% |
| Q1 2020 | $393,000 | -2.7% | 4,835 | 0.0% | 0.04% | +24.2% |
| Q4 2019 | $404,000 | +1.3% | 4,835 | +6.0% | 0.03% | -10.8% |
| Q3 2019 | $399,000 | +7.0% | 4,560 | 0.0% | 0.04% | +8.8% |
| Q2 2019 | $373,000 | +6.0% | 4,560 | 0.0% | 0.03% | -5.6% |
| Q1 2019 | $352,000 | +17.3% | 4,560 | 0.0% | 0.04% | -5.3% |
| Q4 2018 | $300,000 | -14.8% | 4,560 | 0.0% | 0.04% | +5.6% |
| Q3 2018 | $352,000 | +4.5% | 4,560 | 0.0% | 0.04% | +16.1% |
| Q2 2018 | $337,000 | +15.8% | 4,560 | 0.0% | 0.03% | -6.1% |
| Q1 2018 | $291,000 | -1.4% | 4,560 | 0.0% | 0.03% | +3.1% |
| Q4 2017 | $295,000 | +2.4% | 4,560 | 0.0% | 0.03% | -5.9% |
| Q3 2017 | $288,000 | +4.3% | 4,560 | 0.0% | 0.03% | +6.2% |
| Q2 2017 | $276,000 | +39.4% | 4,560 | +20.0% | 0.03% | +52.4% |
| Q1 2017 | $198,000 | +482.4% | 3,800 | +400.0% | 0.02% | +425.0% |
| Q4 2016 | $34,000 | -98.4% | 760 | -83.3% | 0.00% | -85.7% |
| Q3 2016 | $2,171,000 | +938.8% | 4,560 | -1.3% | 0.03% | +12.0% |
| Q2 2016 | $209,000 | -33.9% | 4,620 | 0.0% | 0.02% | -34.2% |
| Q1 2015 | $316,000 | -6.8% | 4,620 | 0.0% | 0.04% | -5.0% |
| Q4 2014 | $339,000 | +2.1% | 4,620 | 0.0% | 0.04% | 0.0% |
| Q3 2014 | $332,000 | -0.6% | 4,620 | 0.0% | 0.04% | -2.4% |
| Q2 2014 | $334,000 | -1.8% | 4,620 | 0.0% | 0.04% | -2.4% |
| Q1 2014 | $340,000 | – | 4,620 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |